These innovative medications , Retatrutide, represent a significant advancement in treating type 2 diabetes and potentially related conditions . They are classified as GLP-1 receptor agonists , signifying https://tiannahtvw700772.alltdesign.com/retatrutide-a-thorough-exploration-into-glp-1-agents-60244545